Rosalinda H. Arends

Efficacy and safety of intramuscular administration of tixagevimab–cilgavimab for early outpatient treatment of COVID-19 (TACKLE): a phase 3, randomised, double-blind, placebo-controlled trial

Hugh Montgomery, Richard Hobbs, Francisco Padilla et al. · The Lancet Respiratory Medicine · 2022 · 223 citations · Full text

Covid-19 Pandemic, Antiviral Therapy, Placebo-controlled Trial +4

The SARS-CoV-2 monoclonal antibody combination, AZD7442, is protective in nonhuman primates and has an extended half-life in humans

Yueh–Ming Loo, Patrick M. McTamney, Rosalinda H. Arends et al. · Science Translational Medicine · 2022 · 208 citations · Full text

Humoral Response, Immunology, Viral Pathogenesis +18

Safety and efficacy of subcutaneous tanezumab in patients with knee or hip osteoarthritis

C. Birbara, Eugene J Dabezies, Aimee Burr et al. · Journal of Pain Research · 2018 · 37 citations · Full text

AZD7442 (Tixagevimab/Cilgavimab) for Post-Exposure Prophylaxis of Symptomatic Coronavirus Disease 2019

Myron J. Levin, Andrew Ustianowski, S. Thomas et al. · Clinical Infectious Diseases · 2022 · 35 citations · Full text

From the Cover: Evaluation of the Effects of Tanezumab, a Monoclonal Antibody Against Nerve Growth Factor, on the Sympathetic Nervous System in Adult Cynomolgus Monkeys (Macaca fascicularis): A Stereologic, Histomorphologic, and Cardiofunctional Assessment

Patrice C. Bélanger, Paul Butler, Mark T. Butt et al. · Toxicological Sciences · 2017 · 30 citations · Full text

Peripheral Nerve Injury, Pain Medicine, Neuropathic Pain +23